Can you draft a progress note for an adult diabetic patient presenting with mild diabetic ketoacidosis (hyperglycemia, elevated anion gap, low serum bicarbonate, β‑hydroxybutyrate ≈1.5 mmol/L)?

Progress Note: Adult Patient with Mild Diabetic Ketoacidosis

Subjective

• Chief Complaint: [Insert patient's presenting symptoms - e.g., polyuria, polydipsia, nausea, abdominal pain, altered mental status]
• History of Present Illness: Adult patient with known/newly diagnosed diabetes mellitus presenting with symptoms consistent with diabetic ketoacidosis. [Include precipitating factors such as infection, medication non-compliance, new diagnosis of diabetes, or other stressors]
• Past Medical History: Diabetes mellitus (Type 1 or Type 2), [other relevant comorbidities]
• Medications: [Current diabetes medications and other relevant medications]
• Social History: [Relevant social factors]

Objective

Vital Signs

• Temperature: [value]
• Heart Rate: [value]
• Blood Pressure: [value]
• Respiratory Rate: [value]
• Oxygen Saturation: [value]
• Mental Status: Alert and oriented vs. altered

Physical Examination

• General: Appears dehydrated vs. well-hydrated
• HEENT: Dry mucous membranes vs. moist
• Cardiovascular: Regular rate and rhythm, no murmurs
• Respiratory: Kussmaul breathing vs. normal respiratory pattern, clear to auscultation bilaterally
• Abdomen: Soft, non-tender vs. diffuse tenderness, normal bowel sounds
• Neurological: Alert and oriented x3 vs. altered mental status
• Skin: Warm and dry vs. cool and clammy, poor turgor vs. normal turgor

Laboratory Data

• Blood Glucose: >250 mg/dL (hyperglycemia present)
• Venous pH: 7.25-7.30 (mild acidosis, >7.0 but <7.3) 1, 2
• Serum Bicarbonate: 10-15 mEq/L (low, but >15 mEq/L for mild DKA) 1, 2
• Anion Gap: Elevated (>10-12 mEq/L)
• β-Hydroxybutyrate: ≈1.5 mmol/L (elevated, indicating ketonemia) 2
• Serum Electrolytes:
  • Sodium: [value]
  • Potassium: [value] - Critical for management
  • Chloride: [value]
  • Magnesium: [value]
• Renal Function: BUN [value], Creatinine [value]
• Serum Osmolality: [value]
• Urinalysis: Ketonuria present

Assessment

Mild Diabetic Ketoacidosis in adult patient with diabetes mellitus, meeting diagnostic criteria: blood glucose >250 mg/dL, venous pH <7.3, bicarbonate <15 mEq/L, and moderate ketonemia (β-hydroxybutyrate ≈1.5 mmol/L) 1, 2, 1.

Severity Classification: Mild DKA based on pH >7.0 and bicarbonate levels 1, 2.

Plan

Fluid Resuscitation

• Initiate 0.9% Normal Saline at clinically appropriate rate to replace estimated 50% of fluid deficit in first 8-12 hours 1
• Monitor hemodynamic status and adjust fluid rate accordingly
• Transition to fluids containing dextrose when blood glucose reaches 200-250 mg/dL to prevent hypoglycemia while continuing insulin therapy 1, 2

Insulin Therapy

For mild DKA, subcutaneous insulin is as effective as intravenous insulin 2:

• Priming dose: 0.4-0.6 units/kg body weight of regular insulin, with half given as IV bolus and half as subcutaneous or intramuscular injection 2
• Maintenance: 0.1 units/kg/hour regular insulin subcutaneously or intramuscularly 2
• Alternative: Continuous IV insulin infusion if patient condition warrants closer monitoring or if subcutaneous route is not feasible 1, 2
• Target glucose decline: 50-75 mg/dL per hour 1
• If glucose does not fall by 50 mg/dL in first hour, verify hydration status and consider doubling insulin dose 1

Electrolyte Management

Potassium Replacement

• Do not start insulin if serum potassium <3.3 mEq/L - replace potassium first to avoid life-threatening arrhythmias 3
• If potassium <5.5 mEq/L and adequate urine output: Add 20-30 mEq potassium (2/3 KCl and 1/3 KPO4) to each liter of IV fluid 1, 3
• Goal: Maintain serum potassium 4-5 mEq/L 3
• Monitor potassium every 2-4 hours during treatment 1

Bicarbonate Therapy

• Not indicated for this patient with pH >7.0 1, 2, 1
• Bicarbonate only considered if pH <6.9 1, 2, 1

Phosphate Replacement

• Not routinely indicated unless serum phosphate <1.0 mg/dL or patient has cardiac dysfunction, anemia, or respiratory depression 1, 2, 1

Monitoring

• Blood glucose: Every 1-2 hours initially, then every 2-4 hours once stable
• Electrolytes, BUN, creatinine, venous pH: Every 2-4 hours until DKA resolves 1, 2, 1
• β-Hydroxybutyrate monitoring preferred over nitroprusside ketone testing, as nitroprusside does not measure β-OHB (the predominant ketone in DKA) and may falsely suggest worsening ketosis during treatment 1, 2
• Venous pH and anion gap can be followed instead of repeated arterial blood gases (venous pH typically 0.03 units lower than arterial pH) 1
• Monitor for signs of cerebral edema (though rare in adults): headache, altered mental status, bradycardia

Resolution Criteria

DKA is considered resolved when ALL of the following are met 1, 2, 1:

• Blood glucose <200 mg/dL
• Serum bicarbonate ≥18 mEq/L
• Venous pH >7.3
• Anion gap normalized (≤12 mEq/L)

Note: β-hydroxybutyrate <1.5 mmol/L correlates with resolution, though ketonemia typically takes longer to clear than hyperglycemia 2, 4

Transition to Subcutaneous Insulin

Once DKA resolves:

• If patient NPO: Continue IV insulin and supplement with subcutaneous regular insulin every 4 hours as needed (5-unit increments for every 50 mg/dL increase above 150 mg/dL, up to 20 units for glucose of 300 mg/dL) 1
• When patient able to eat: Initiate basal-bolus regimen with combination of short/rapid-acting and intermediate/long-acting insulin 1, 2, 1
• Critical: Continue IV insulin for 1-2 hours after starting subcutaneous basal insulin to ensure adequate plasma insulin levels and prevent rebound hyperglycemia or recurrent DKA 2, 5

Identify and Treat Precipitating Factors

• [Evaluate for infection, medication non-compliance, myocardial infarction, stroke, or other stressors]
• [Order appropriate cultures, imaging, or consultations as indicated]

Disposition

• Admit to appropriate level of care based on clinical status and ability to monitor closely
• Mild DKA may be managed on medical floor with frequent monitoring
• Consider ICU admission if hemodynamically unstable, altered mental status, or requiring continuous IV insulin infusion

Discharge Planning (when appropriate)

• Diabetes self-management education prior to discharge 5, 6
• Medication reconciliation with attention to access 5, 6
• Education on recognition, prevention, and management of DKA to prevent recurrence 6
• Scheduled follow-up with primary care provider and/or endocrinologist 5
• Ensure patient has prescriptions for insulin, glucose monitoring supplies, and ketone testing strips 5

---

Common Pitfalls to Avoid:

• Do not abruptly discontinue IV insulin without overlapping with subcutaneous basal insulin for 1-2 hours, as this leads to poor glycemic control and potential DKA recurrence 2
• Do not start insulin if potassium <3.3 mEq/L - this can cause life-threatening arrhythmias 3
• Do not rely on nitroprusside ketone testing to monitor treatment response, as it does not measure β-OHB and may falsely suggest worsening ketosis 1, 2
• Do not use overly aggressive fluid resuscitation - aim for gradual correction to avoid cerebral edema risk 1
• Do not stop insulin when glucose normalizes - continue insulin until acidosis resolves, adding dextrose-containing fluids to prevent hypoglycemia 1, 2